ZR2021MH268/Natural Science Foundation of Shandong Province[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

ILT4 facilitates angiogenesis in non-small cell lung cancer.

Wang S, Wang J, Gong W, Zhang F, Chen X, Xu H, Han Y, Fu X, Wang L, Li J, Gao A, Sun Y. Wang S, et al. Cancer Sci. 2024 May;115(5):1459-1475. doi: 10.1111/cas.16126. Epub 2024 Mar 3. Cancer Sci. 2024. PMID: 38433526 Free PMC article.

Correlation between immune-related adverse events and efficacy of PD-(L)1 inhibitors in small cell lung cancer: a multi-center retrospective study.

Zhang J, Gao A, Wang S, Sun Y, Wu J, Wang D, Ge Y, Li J, Sun H, Cheng Q, Sun Y. Zhang J, et al. Respir Res. 2024 Jun 21;25(1):256. doi: 10.1186/s12931-024-02890-3. Respir Res. 2024. PMID: 38907273 Free PMC article.

Efficacy of first-line treatment options beyond RET-TKIs in advanced RET-rearranged non-small cell lung cancer: A multi-center real-world study.

Ge Y, Li J, Gong W, Wang J, Wei X, Liu J, Wang S, Wang L, Sun H, Cheng Q, Sun Y, Dang Q, Sun Y, Gao A. Ge Y, et al. Cancer Med. 2024 Jan;13(2):e6960. doi: 10.1002/cam4.6960. Cancer Med. 2024. PMID: 38349001 Free PMC article.

PD-(L)1 inhibitors plus bevacizumab and chemotherapy as first-line therapy in PD-L1-negative metastatic lung adenocarcinoma: a real-world data.

Ge Y, Zhan Y, He J, Li J, Wang J, Wei X, Wang C, Gao A, Sun Y. Ge Y, et al. J Cancer Res Clin Oncol. 2024 Mar 18;150(3):135. doi: 10.1007/s00432-024-05637-1. J Cancer Res Clin Oncol. 2024. PMID: 38499838 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters